SEQUENOM Announces Partnership With GeneWorks for Sales & Market

SAN DIEGO, Sept. 9 /PRNewswire-FirstCall/ -- SEQUENOM, Inc. (Nasdaq: SQNM) and GeneWorks Pty. Ltd. today announced an exclusive sales agency agreement under which GeneWorks will assist SEQUENOM in expanding its sales & marketing presence in Australia. The partnership will initially focus on new business development activity across Australia. GeneWorks has significant experience and a strong reputation in the supply of genomics technologies and reagents and is an Australian manufacturer of high quality oligonucleotides and offers a range of genetic analysis services including Next Generation Sequencing services.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO)

Given our introduction of the new MassARRAY Compact 96 system, OncoCarta oncogene mutation profiling panel, and our expansion into translational and clinical research sectors, we are excited about the capabilities that GeneWorks brings to assist us in expanding our customer base in Australia, said Mike Monko, senior vice president of sales & marketing at SEQUENOM. Australia remains a key market for us in the Asia Pacific region and with our ongoing direct presence in Australia through our Asia Pacific office based in Queensland, we expect to see substantial business growth in this region over the coming years.

Peter Guilhaus, managing director of GeneWorks added, We\'re excited and pleased to be partnering with SEQUENOM in Australia. SEQUENOM\'s MassARRAY system and related kits complement our product and services portfolio nicely. We\'re looking forward to supporting this powerful technology, and in conjunction with our oligo and genome analysis services, providing our customers with a comprehensive solution to their research needs.